Measles, chickenpox vaccines okay for preemies

Tue Mar 13, 2007 10:34pm EDT
 
[-] Text [+]

By David Douglas

NEW YORK (Reuters Health) - Infants born extremely preterm mount similar immune responses as those born at term to the measles-mumps-rubella (MMR) vaccine and the chickenpox vaccine, a study shows.

"We do these studies because assuming what is right for full-term babies is right for very premature babies sometimes leads us to the wrong decisions," lead author Dr. Carl T. D'Angio told Reuters Health.

D'Angio of the University of Rochester, New York, and colleagues compared the immune status before and after immunization with MMR and chickenpox vaccines at 15 months in 32 infants.

Sixteen of the infants were born very prematurely at less than 29 weeks' gestation and the other 16 infants were born at term. Blood was drawn before vaccination and at 3 to 6 weeks thereafter.

The researchers found, as mentioned, that the premature infants responded as well as the full term infants to MMR vaccination and chickenpox vaccination.

"These findings," concluded D'Angio, "should reassure pediatricians and the families of premature babies that giving the MMR and (chickenpox) shots on time is the best way to protect these children from these diseases."

SOURCE: Pediatrics, March 2007.

 
Dr. Qurrath U. Ain of the Elmhurst Pediatric Emergency Center examines a patient with flu-like symptoms at Elmhurst Hospital in New York in this December 12, 2003. file photo. REUTERS/Shannon Stapleton/Files
Healthcare Reform

Reuters provides an in-depth look at the issues facing Americans as the Obama administration wrestles with healthcare policy.  Full Coverage 

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
Uninsured patient Josefa Martinez, 8, has her blood pressure measured during a health check-up at Venice Family Clinic in Venice, California, June 25, 2009.  REUTERS/Lucy Nicholson
The healthcare disconnect

A successful reform package will have to address the cost for services for private versus public providers and employ innovative technological advances, writes Darrell West, author of Digital Medicine: Health Care in the Internet Era.  Commentary | Full Coverage 

Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better